Literature DB >> 21145819

Overexpression of the IGF2-mRNA binding protein p62 in transgenic mice induces a steatotic phenotype.

Elisabeth Tybl1, Fu-Dong Shi, Sonja M Kessler, Sascha Tierling, Jörn Walter, Rainer M Bohle, Stefan Wieland, Jianying Zhang, Eng M Tan, Alexandra K Kiemer.   

Abstract

BACKGROUND & AIMS: The insulin-like growth-factor 2 (IGF2) mRNA binding protein p62 is highly expressed in hepatocellular carcinoma tissue. Still, its potential role in liver disease is largely unknown. In this study, we investigated pathophysiological implications of p62 overexpression in mice.
METHODS: We generated mice overexpressing p62 under a LAP-promotor. mRNA expression levels and stability were examined by real-time RT-PCR. Allele-specific expression of Igf2 and H19 was assessed after crossing mice with SD7 animals. The Igf2 downstream mediators pAKT and PTEN were determined by Western blot.
RESULTS: Hepatic p62 overexpression neither induced inflammatory processes nor liver damage. However, 2.5week old transgenic animals displayed a steatotic phenotype and improved glucose tolerance. p62 overexpression induced the expression of the imprinted genes Igf2 and H19 and their transcriptional regulator Aire (autoimmune regulator). Neither monoallelic expression nor mRNA stability of Igf2 and H19 was affected. Investigating Igf2 downstream signalling pathways showed increased AKT activation and attenuated PTEN expression.
CONCLUSIONS: The induction of a steatotic phenotype implies that p62 plays a role in hepatic pathophysiology.
Copyright © 2010 European Association for the Study of the Liver. Published by Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21145819      PMCID: PMC3079004          DOI: 10.1016/j.jhep.2010.08.034

Source DB:  PubMed          Journal:  J Hepatol        ISSN: 0168-8278            Impact factor:   25.083


  48 in total

1.  Influence of risk factors for metabolic syndrome and non-alcoholic fatty liver disease on the progression and prognosis of hepatocellular carcinoma.

Authors:  Susumu Takamatsu; Norio Noguchi; Atsushi Kudoh; Noriaki Nakamura; Tohru Kawamura; Kenichi Teramoto; Tohru Igari; Shigeki Arii
Journal:  Hepatogastroenterology       Date:  2008 Mar-Apr

2.  RNA-binding protein insulin-like growth factor II mRNA-binding protein 3 expression promotes tumor invasion and predicts early recurrence and poor prognosis in hepatocellular carcinoma.

Authors:  Yung-Ming Jeng; Cheng-Chi Chang; Fu-Chang Hu; Han-Yi E Chou; Hsin-Lien Kao; Ting-Huang Wang; Hey-Chi Hsu
Journal:  Hepatology       Date:  2008-10       Impact factor: 17.425

3.  Sulfasalazine sensitises human monocytic/macrophage cells for glucocorticoids by upregulation of glucocorticoid receptor alpha and glucocorticoid induced apoptosis.

Authors:  Ruud Oerlemans; Josefien Vink; Ben A C Dijkmans; Yehuda G Assaraf; Marjolein van Miltenburg; Joost van der Heijden; Ilan Ifergan; Willem F Lems; Rik J Scheper; Gertjan J L Kaspers; Jacqueline Cloos; Gerrit Jansen
Journal:  Ann Rheum Dis       Date:  2007-01-31       Impact factor: 19.103

4.  Unsaturated fatty acids inhibit the expression of tumor suppressor phosphatase and tensin homolog (PTEN) via microRNA-21 up-regulation in hepatocytes.

Authors:  Manlio Vinciguerra; Antonino Sgroi; Christelle Veyrat-Durebex; Laura Rubbia-Brandt; Leo H Buhler; Michelangelo Foti
Journal:  Hepatology       Date:  2009-04       Impact factor: 17.425

Review 5.  Portrait of PTEN: messages from mutant mice.

Authors:  Akira Suzuki; Toru Nakano; Tak Wah Mak; Takehiko Sasaki
Journal:  Cancer Sci       Date:  2008-01-15       Impact factor: 6.716

6.  Unsaturated fatty acids promote hepatoma proliferation and progression through downregulation of the tumor suppressor PTEN.

Authors:  Manlio Vinciguerra; Fabio Carrozzino; Marion Peyrou; Sebastiano Carlone; Roberto Montesano; Roberto Benelli; Michelangelo Foti
Journal:  J Hepatol       Date:  2009-04-01       Impact factor: 25.083

7.  Coactivation of ATM/ERK/NF-kappaB in the low-dose radiation-induced radioadaptive response in human skin keratinocytes.

Authors:  Kazi Mokim Ahmed; Danupon Nantajit; Ming Fan; Jeffrey S Murley; David J Grdina; Jian Jian Li
Journal:  Free Radic Biol Med       Date:  2009-03-24       Impact factor: 7.376

8.  Bcl-2 upregulation after 3-nitropropionic acid preconditioning in warm rat liver ischemia.

Authors:  Friedrich Dünschede; Elisabeth Tybl; Alexandra K Kiemer; Philipp Dutkowski; Kirsten Erbes; Achim Kircher; Ines Gockel; Ulrich Zechner; Arno Schad; Hauke Lang; Theodor Junginger; Oliver Kempski
Journal:  Shock       Date:  2008-12       Impact factor: 3.454

9.  The H19 locus acts in vivo as a tumor suppressor.

Authors:  Tomomi Yoshimizu; Audrey Miroglio; Marie-Anne Ripoche; Anne Gabory; Maria Vernucci; Andrea Riccio; Sabine Colnot; Cécile Godard; Benoit Terris; Hélène Jammes; Luisa Dandolo
Journal:  Proc Natl Acad Sci U S A       Date:  2008-08-21       Impact factor: 11.205

10.  Alterations in methylation and expression levels of imprinted genes H19 and Igf2 in the fetuses of diabetic mice.

Authors:  Wei-Juan Shao; Ling-Yun Tao; Cheng Gao; Jian-Yun Xie; Ru-Qian Zhao
Journal:  Comp Med       Date:  2008-08       Impact factor: 0.982

View more
  22 in total

1.  Rapid chromatographic method to decipher distinct alterations in lipid classes in NAFLD/NASH.

Authors:  Stephan Laggai; Yvette Simon; Theo Ranssweiler; Alexandra K Kiemer; Sonja M Kessler
Journal:  World J Hepatol       Date:  2013-10-27

2.  The IGF2 mRNA binding protein p62/IGF2BP2-2 induces fatty acid elongation as a critical feature of steatosis.

Authors:  Stephan Laggai; Sonja M Kessler; Stefan Boettcher; Valérie Lebrun; Katja Gemperlein; Eva Lederer; Isabelle A Leclercq; Rolf Mueller; Rolf W Hartmann; Johannes Haybaeck; Alexandra K Kiemer
Journal:  J Lipid Res       Date:  2014-04-22       Impact factor: 5.922

3.  IGF2BP2/IMP2-Deficient mice resist obesity through enhanced translation of Ucp1 mRNA and Other mRNAs encoding mitochondrial proteins.

Authors:  Ning Dai; Liping Zhao; Diedra Wrighting; Dana Krämer; Amit Majithia; Yanqun Wang; Valentin Cracan; Diego Borges-Rivera; Vamsi K Mootha; Matthias Nahrendorf; David R Thorburn; Liliana Minichiello; David Altshuler; Joseph Avruch
Journal:  Cell Metab       Date:  2015-04-07       Impact factor: 27.287

4.  Elevated free cholesterol in a p62 overexpression model of non-alcoholic steatohepatitis.

Authors:  Yvette Simon; Sonja M Kessler; Katja Gemperlein; Rainer M Bohle; Rolf Müller; Johannes Haybaeck; Alexandra K Kiemer
Journal:  World J Gastroenterol       Date:  2014-12-21       Impact factor: 5.742

Review 5.  Endoplasmic Reticulum Stress and Autophagy in the Pathogenesis of Non-alcoholic Fatty Liver Disease (NAFLD): Current Evidence and Perspectives.

Authors:  Christina-Maria Flessa; Ioannis Kyrou; Narjes Nasiri-Ansari; Gregory Kaltsas; Athanasios G Papavassiliou; Eva Kassi; Harpal S Randeva
Journal:  Curr Obes Rep       Date:  2021-03-22

6.  Loss of Hilnc prevents diet-induced hepatic steatosis through binding of IGF2BP2.

Authors:  Yiao Jiang; Jiayin Peng; Jiawen Song; Juan He; Man Jiang; Jia Wang; Liya Ma; Yuang Wang; Moubin Lin; Hailong Wu; Zhao Zhang; Dong Gao; Yun Zhao
Journal:  Nat Metab       Date:  2021-11-08

7.  Tissue-specific relationship of S-adenosylhomocysteine with allele-specific H19/Igf2 methylation and imprinting in mice with hyperhomocysteinemia.

Authors:  Melissa B Glier; Ying F Ngai; Dian C Sulistyoningrum; Rika E Aleliunas; Teodoro Bottiglieri; Angela M Devlin
Journal:  Epigenetics       Date:  2012-12-05       Impact factor: 4.528

8.  Human Insulin Growth Factor 2 mRNA Binding Protein 2 Increases MicroRNA 33a/b Inhibition of Liver ABCA1 Expression and Alters Low-Density Apolipoprotein Levels in Mice.

Authors:  Muhua Yang; Christina Gallo-Ebert; Michael Hayward; Weidong Liu; Virginia McDonough; Joseph T Nickels
Journal:  Mol Cell Biol       Date:  2020-07-29       Impact factor: 4.272

Review 9.  Strategies, models and biomarkers in experimental non-alcoholic fatty liver disease research.

Authors:  Joost Willebrords; Isabel Veloso Alves Pereira; Michaël Maes; Sara Crespo Yanguas; Isabelle Colle; Bert Van Den Bossche; Tereza Cristina Da Silva; Cláudia Pinto Marques Souza de Oliveira; Wellington Andraus; Venâncio Avancini Alves; Bruno Cogliati; Mathieu Vinken
Journal:  Prog Lipid Res       Date:  2015-06-11       Impact factor: 16.195

Review 10.  The biological function of IGF2BPs and their role in tumorigenesis.

Authors:  Qiu-Ying Du; Zhi-Man Zhu; Dong-Sheng Pei
Journal:  Invest New Drugs       Date:  2021-07-12       Impact factor: 3.850

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.